|Anderson School at UCLA, MBA|
Stephen Watkins is a founding partner of Arcturus Capital, an early stage venture capital firm focused on Southern California companies. Arcturus has $32MM under management and currently has a portfolio of fourteen companies. Mr. Watkins is currently a chairman for Ondax, Inc., a board member at Chimeros and Prolacta Biosciences, and a board observer at SupplyFrame and Digital Performance, Inc.
Prior to Arcturus, Mr. Watkins had extensive experience in financing and operating technology companies. In 1999, he co-founded The Start Group, a technology accelerator dedicated to the development of start-up companies in Southern California. The company established networks between large service providers to technology companies, investors and institutions, such as the California Institute for Technology. In 2000, The Start Group facilitated the financing of over $50 million in private equity.
Prior to his work in venture capital and technology development, Mr. Watkins founded Trigenics Technology, Inc, a pathology and bio-informatics company developed with scientific partners from UCLA medical Center. Trigenics provided genomics, proteomics and diagnostic companies with raw data for their research protocols.